☰

Stephanie E. Busch, Ph.D. - Publications

Affiliations: 
2012 Molecular and Cellular Biology University of Washington, Seattle, Seattle, WA 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Mark NM, Kargl J, Busch SE, Yang GHY, Metz HE, Zhang H, Hubbard JJ, Pipavath SNJ, Madtes DK, Houghton AM. COPD Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in NSCLC. American Journal of Respiratory and Critical Care Medicine. PMID 28934595 DOI: 10.1164/Rccm.201704-0795Oc  0.408
2017 Kargl J, Busch SE, Yang GH, Kim KH, Hanke ML, Metz HE, Hubbard JJ, Lee SM, Madtes DK, McIntosh MW, Houghton AM. Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nature Communications. 8: 14381. PMID 28146145 DOI: 10.1038/Ncomms14381  0.418
2016 Busch SE, Hanke ML, Kargl J, Metz HE, MacPherson D, Houghton AM. Lung Cancer Subtypes Generate Unique Immune Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 27799309 DOI: 10.4049/Jimmunol.1600576  0.529
2016 Metz HE, Kargl J, Busch SE, Kim KH, Kurland BF, Abberbock SR, Randolph-Habecker J, Knoblaugh SE, Kolls JK, White MF, Houghton AM. Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27439864 DOI: 10.1073/Pnas.1601989113  0.478
2016 Busch SE, Kargl J, Hanke ML, Metz HE, Kim K, Houghton AM. Abstract PR04: Inflammatory responses within the lung tumor microenvironment correlate with oncogenic mutation and histologic subtype Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Pr04  0.558
2016 Metz HE, Kargl J, Busch S, Kim K, Houghton M. Abstract B26: Novel pro-host role for insulin receptor substrate-1 in lung adenocarcinoma Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B26  0.503
2015 Hanke ML, Busch SE, Kargl J, Kim KH, Houghton AM. Abstract 3182: Reduced tumor burden and mortality in IL-17RA-deficient EGFR mutant mice Immunology. 75: 3182-3182. DOI: 10.1158/1538-7445.Am2015-3182  0.39
2015 Busch SE, Hanke ML, Kim KH, Kargl J, Houghton AM. Abstract 3181: EGFR and KRAS activation generate discrete inflammatory responses within the lung tumor microenvironment Immunology. 75: 3181-3181. DOI: 10.1158/1538-7445.Am2015-3181  0.482
2015 Metz H, Busch SE, Kargl J, Hanke ML, Kim K, Houghton AM. Abstract 2354: Insulin receptor substrate-1 regulates immune cell content in lung adenocarcinoma Cancer Research. 75: 2354-2354. DOI: 10.1158/1538-7445.Am2015-2354  0.538
2015 Kargl J, Kim K, Busch SE, Hanke ML, Metz HE, McIntosh MW, Houghton AM. Abstract 1290: Distinct immune cell composition for lung squamous cell carcinoma (SCCA) and adenocarcinoma (ADCA) Cancer Research. 75: 1290-1290. DOI: 10.1158/1538-7445.Am2015-1290  0.504
2015 Kargl J, Busch S, Metz H, Kim K, Houghton A. 247 Distinct immune cell composition for lung squamous cell carcinoma (SCCA) and adenocarcinoma (ADCA) European Journal of Cancer. 51: S42. DOI: 10.1016/S0959-8049(16)30133-2  0.314
2014 Kemp CJ, Moore JM, Moser R, Bernard B, Teater M, Smith LE, Rabaia NA, Gurley KE, Guinney J, Busch SE, Shaknovich R, Lobanenkov VV, Liggitt D, Shmulevich I, Melnick A, et al. CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer. Cell Reports. 7: 1020-9. PMID 24794443 DOI: 10.1016/J.Celrep.2014.04.004  0.56
2014 Busch SE, Moser RD, Gurley KE, Kelly-Spratt KS, Liggitt HD, Kemp CJ. ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma. Oncogene. 33: 2665-73. PMID 23752194 DOI: 10.1038/Onc.2013.208  0.636
2014 Metz HE, Busch SE, Hanke ML, Kargl J, Kim K, Houghton AM. Abstract 4860: Insulin receptor substrate-1 regulates immune cell content in lung adenocarcinoma Cancer Research. 74: 4860-4860. DOI: 10.1158/1538-7445.Am2014-4860  0.496
2012 Busch SE, Gurley KE, Moser RD, Kemp CJ. ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model. The Journal of Pathology. 227: 298-305. PMID 22430984 DOI: 10.1002/Path.4024  0.463
2011 Busch SE, Gurley KE, Moser RD, Kelly-Spratt KS, Kemp CJ. Abstract A34: Arf suppresses the growth and progression of Kras-driven lung tumors Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A34  0.64
Show low-probability matches.